Description

This issue of Vital Signs, released on October 5, 2009, provides a strategic overview of the opportunity of transcatheter valves in the medical devices space. Additionally, a company spotlight is provided for Cardiac Dimensions, Inc., an emerging company focused on offering new avenues of treatment for underserved CHF patients. Reimbursement and regulatory news from the FDA is also provided for the week of September 21, 2009.